Archive

Category Archives for "Press Releases"

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw, a unit of H.C Wainwright, in a $3.9 Million Public Offering of Medical Transcript Billing, Corp.

mtbc - medical transcription billing corp. logo

Press Release – New York, NY – December 11, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $6.58 Million Registered Direct Offering and Concurrent Private Placement

pareteum logo

Press Release – New York, NY – December 6, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSE American: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in a registered direct offering and private placement offering of 7,151,146 shares of common stock and restricted five-year warrants to purchase up to 7,151,146 shares of common stock exercisable at $1.09 per warrant.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents CloudCommerce, Inc., in Acquisition of WebTegrity, LLC

Press Release – New York, NY – November 17, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented CloudCommerce, Inc., a global provider of cloud-driven e-commerce and mobile commerce solutions, in its acquisition of WebTegrity, LLC (“WebTegrity”), a provider of enterprise digital marketing services based in San Antonio, Texas, through a merger with and into Parscale Digital, Inc., a wholly owned subsidiary of CloudCommerce, Inc.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents MabVax Therapeutics Holdings, Inc. in $5 Million Registered Direct Offerings

mabvax therapeutics

Press Release – New York, NY – November 15, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, in a series of registered direct offerings of  common stock and preferred stock for aggregate gross proceeds of approximately $5,000,000.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. in $1.4 Million Registered Direct Offering

onconova logo

Press Release – New York, NY – November 14, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as sole placement agent in the registered direct offering of common stock securities of Onconova Therapeutics, Inc.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $12.0 Million Firm Commitment Public Offering

pareteum logo

Press Release – New York, NY – November 9, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSE American: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in a firm commitment underwritten offering of 9,009,478 shares of common stock, 4,034 shares of preferred stock (each of which shares is an equivalent of 920 shares of common stock), and five-year warrants to purchase up to 7,478,228 shares of common stock exercisable at $1.05 per warrant.

continue reading >>

Sichenzia Ross Ference Kesner LLP Congratulates AYTU Biosciences, Inc., on NASDAQ Uplisting

aytu bioscience

Press Release – New York, NY – October 19, 2017 –  Sichenzia Ross Ference Kesner LLP announced today that the Firm represented AYTU Biosciences, Inc. (NASDAQ: AYTU), in the Company’s up-listing to the NASDAQ Capital Market. The Sichenzia Ross Ference Kesner LLP team was led by founding Partner Gregory Sichenzia and Partner Marcelle Balcombe. The up-listing is effective for trading on October 20, 2017 and AYTU’s common stock will trade under its existing stock symbol “AYTU.”

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $6.75 Million Registered Direct Offering of Common Stock of Ampio Pharmaceuticals, Inc.

Press Release – New York, NY – October 18, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co.  as Lead Placement Agent and Fordham Financial Management Co-Placement Agent  in a $6.75 million Registered Direct Public Offering of Common Stock of Ampio Pharmaceuticals, Inc. (“NYSE.AMPE”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $1.56 Million Shelf Take Down

pareteum logo

Press Release – New York, NY – October 12, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Pareteum Corporation (“Pareteum”), a rapidly growing mobile Cloud Communications Platform company, in connection with its shelf take down of 1,495,000 shares of its common stock. Gross proceeds to Pareteum from this offering are $1,569,750 before deducting placement agent’s commissions and other expenses.  Dawson James Securities acted as placement agent for the offering.

The Sichenzia Ross Ference Kesner LLP team was led by Partner Darrin M. Ocasio, Counselors Jeffrey Cahlon, and Cheryll J. Calaguio and Associate Evan Berger.

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

Visit SRFK's LinkedIn page
Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP Cited as Top-Ranked Legal Counsel for PIPE Issuers in the Third Quarter 2017

Press Release — October 3, 2017 — New York, NY — Sichenzia Ross Ference Kesner LLP was recently cited as the top-ranked issuer legal counsel with eight PIPE placements advised in the third quarter 2017, according to The Deal.  The Deal’s exclusive League Table ranking tracks PIPEs that raise at least $1 million between January 1 and September 15, 2017. To read the press release, please click here.

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in a $6.0 Million Public Offering of Medical Transcript Billing, Corp.

mtbc.com logo

Press Release – New York, NY – September 28, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

continue reading >>

Sichenzia Ross Ference Kesner LLP Real Estate Group Represents One Wall Partners in a $63 Million, 16-Building, Portfolio Acquisition

one wall partners

Press Release – New York, NY – September 20, 2017 – The real estate practice group of SRFK announced today that it recently closed on a $63 million, 16 building, multi-family, portfolio acquisition for One Wall Partners.  One Wall Partners is a vertically integrated real estate investment firm that specializes in the acquisition, development and management of transit-oriented workforce housing.  The Sichenzia Ross Ference Kesner LLP team was led by partner Anthony Ficara, counsel Michael Wickersham and associate Laura Kim.

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar & Co., LLC in $10 Million Public Offering of American Depository Shares of BiondVax Pharmaceuticals Ltd. (Israel)

biondvax pharmaceuticals

Press Release – New York, NY – September 19, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC. as sole book running manager in the underwritten public offering of American Depository Shares (ADS’s) of BiondVax Pharmaceuticals, Ltd. (NASDAQ: BVXV, TASE BVXV), a clinical stage biopharmaceutical company focused on developing a universal flu vaccine. The public offering consisted of 1,500,000 ADS’s and the full overallotment of 166,667 additional ADS’s at a public offering price of $6.00 per ADS for gross proceeds of $10 million.  The Sichenzia Ross Ference Kesner LLP team was led by partners Gregory Sichenzia and Avital Perlman, Counsel Jeffrey Cahlon and Associate Evan Berger.

Los Angeles Times Interviews Gregory Sichenzia on Google’s Potential Investment in Lyft

Press Release – New York, NY – September 17, 2017 – Founding Partner Gregory Sichenzia spoke with the Los Angeles Times’ technology reporter Tracey Lien to discuss the impact of a potential investment in Lyft by Google, as the technology giant already has a size-able investment in Uber, another ride sharing company. Sichenzia was quoted numerous times throughout the article, which can be found here.

Sichenzia Ross Ference Kesner LLP Represents Aegis Capital Corp. in $6 Million Public Offering of Units of Precipio, Inc.

precipio diagnostics

Press Release – New York, NY – August 23rd, 2017 –  Sichenzia Ross Ference Kesner LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of Units of Precipio, Inc. (NASDAQ: PRPO). Each Unit is comprised of 1 share of Series B Preferred Stock which is convertible into 400 shares of common stock at a price of $2.50 per share and one warrant to purchase 400 shares of common stock at $3.00 per share.   Precipio provides diagnostic information to physicians and there patients worldwide.  The Sichenzia Ross Ference Kesner LLP team was led by partner Tom Rose and counsel Jeff Cahlon.

Sichenzia Ross Ference Kesner LLP Relocates NYC Headquarters

Sichenzia Ross Ference Kesner LLP is pleased to announce that as of August 25, 2017 we have moved to a new location at 1185 Avenue of the Americas, 37th Floor, New York, NY 10036.

As we enter our 20th year as a leading corporate, securities and litigation law firm, and expand our practice areas to include real estate and trusts and estates, our move to this vibrant mid-town New York City location will help us to better serve our diverse client base in New York and around the world.

This new location provides our many colleagues and clients with facilitated ease of travel in and out of the city. We will share photos of the new office space as soon as we have them. Please feel free to contact marketing@srfkllp.com with any questions — we hope to see you soon in our new home!

Partner Benjamin Tan Joins China Internet Nationwide Financial Services, Inc. in Ringing the Closing Bell at Nasdaq MarketSite

Press Release – New York, NY – August 16, 2017 – Sichenzia Ross Ference Kesner LLP partner,  Benjamin Tan joined China Internet Nationwide Financial Services, Inc. (NASDAQ: CIFS) , a provider of financial advisory services to the underserved small-to-medium sized enterprises in China, in ringing the closing bell at Nasdaq MarketSite in Times Square on August 15, 2017. CIFS recently closed on an initial public offering of 2,023,146 ordinary shares for a total of $20,231,460 at $10.00 per share on July 31, 2017  and its shares currently trade on the NASDAQ Global Market.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $11.8 PIPE financing of Aytu Bioscience, Inc.

aytu bioscience

Press Release – New York, NY – November 2, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co.  as lead placement agent and Fordham Financial Management, Inc. co-placement agent  in a private placement offering of equity securities of Aytu BioScience, Inc.  (OTC Market “AYTU”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $8.6 Million Registered Direct Offering

vuzix view the future logo

Press Release – New York, NY – August 14, 2016 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 1.5 million registered shares of its common stock at a price of $5.75 per share  for gross proceeds to Vuzix of $8,625,000.Chardan Capital Markets LLC acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Thomas Rose, and Counsel Jeff Cahlon.

Sichenzia Ross Ference Kesner LLP Represents JetSmarter Inc. in Institutional Investment from Clearlake Capital Group and Leucadia National Corporation

jetsmarter_logo

Press Release — August 10, 2017 — New York, NY — Sichenzia Ross Ference Kesner LLP represented JetSmarter Inc., an innovative technology company and market leader in the premium private-flight-sharing economy, in an institutional capital raise.  The investment was anchored by lead sponsor, Clearlake Capital Group, L.P. and included participation from Leucadia National Corporation and existing investors.  Jefferies LLC acted as the exclusive placement agent to JetSmarter Inc. in connection with the financing.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents CloudCommerce, Inc., in Acquisition of Parscale Creative, Inc.

cloudcommerce inc

Press Release – New York, NY – August 2, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented CloudCommerce, Inc., a global provider of cloud-driven e-commerce and mobile commerce solutions, in its acquisition of Parscale Creative, Inc., a company engaged in the digital marketing business, through a forward triangular merger with Parscale Digital, Inc., a newly formed wholly owned subsidiary of CloudCommerce, Inc.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Medovex Corp. in Registered Direct Offering

medovex corporation

Press Release — New York, NY — August 2, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented Medovex Corp. (NASDAQ:MDVX), a medical products manufacturer, in a registered direct offering of units consisting of 2,956,046 shares of common stock and 1,478,023 warrants to purchase common stock at a price of $0.91 per unit resulting in gross proceeds of $2,680,000.

The Sichenzia Ross Ference Kesner LLP team was led by partners Harvey Kesner and Arthur Marcus. continue reading >>

Sichenzia Ross Ference Kesner LLP Represents China Internet Nationwide Financial Services Inc. on $20 Million Public Offering

china internet nationwide financial services

Press Release – New York, NY – July 31, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS), a provider of financial advisory services to the underserved small-to-medium sized enterprises in China, in an initial public offering of 2,023,146 ordinary shares for a total of $20,231,460 at $10.00 per share. The shares are expected to begin trading on the NASDAQ Global Market on August 8, 2017 under the symbol “CIFS.”

continue reading >>

Sichenzia Ross Ference Kesner’s Jodi Zimmerman Conducts Q&A on “What You Should Know About Creating A Last Will & Testament”

Press Release – New York, NY – July 26, 2017 – Jodi B. Zimmerman, Esq. of Sichenzia Ross Ference Kesner LLP participated in a Q&A blog post hosted by eSignatureGuarantee Group, to share “What You Should Know About Creating A Last Will & Testament.” The Q&A outlines the reasons for planning ahead, what to be aware of, and most importantly — the impact on your family and community.

Read the entire post here.

Partner Harvey Kesner Rings Nasdaq Opening Bell with Laidlaw & Company (UK) Ltd. and Therapix Biosciences Ltd.

Press Release – New York, NY – June 28, 2017 – Sichenzia Ross Ference Kesner LLP partner Harvey Kesner joined representatives of Laidlaw & Company (UK) Ltd. and Therapix Biosciences Ltd., at the Nasdaq MarketSite in Times Square to ring the June 28, 2017 opening bell.

Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs. The company’s American Depository Shares (ADSs) have traded on The Nasdaq Capital Market under the symbol “TRPX” since March 22, 2017.

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in a $7.4 Million Public Offering of Medical Transcript Billing, Corp.

mtbc - medical transcription billing corp. logo

Press Release – New York, NY – June 23, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcription Billing, Corp. (MTBC.NASDAQ). MTBC is a principal provider of proprietary, cloud-based electronic health records, practice management, and mHealth solutions.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Immuron Limited on $6.1M IPO and NASDAQ listing

immuron

Press Release — New York, NY — June 14, 2017 — Sichenzia Ross Ference Kesner LLP (“SRFK”) announced today the Firm has represented Immuron Limited (NASDAQ: IMRN) (ASX : IMC), a clinical-stage biopharmaceutical company focused on NASH and OTC products, on the company’s U.S. underwritten public offering of American Depository Shares (ADSs) and warrants to purchase the company’s ADSs at a combined offering price of $10.00.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, and Fordham Financial Management in $6.6 Registered Direct offering of Ampio Pharmaceuticals, Inc.

ampio pharmaceuticals

Press Release – New York, NY – June 8, 2017 – Nationally recognized securities and corporate law firm, Sichenzia Ross Ference Kesner LLP, announced today that it has represented Joseph Gunnar & Co. as Lead Placement agent and Fordham Financial Management as Co-Placement Agent  in a $6.6 million Registered Direct public offering of equity securities of Ampio Pharmaceuticals, Inc.(“NYSE MKT.AMPE”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Announces the Addition of an Established Commercial Real Estate Practice Group and Trust & Estates Practice Area

Press Release – New York, NY – June 7, 2017 – Sichenzia Ross Ference Kesner LLP (SRFK), a leading corporate securities and full service law firm, is pleased to announce the addition of a Commercial Real Estate group and Trusts & Estates practice to its growing number of practice areas.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents MabVax Therapeutics Holdings, Inc. on $4.1 Million Public Offering

mabvax therapeutics

Press Release – New York, NY – June 5, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX), a clinical-stage oncology drug development company, in a public offering of common stock and Series G Preferred Stock for a total of $4.1 million. continue reading >>

Sichenzia Ross Ference Kesner LLP Advises Dataram Corporation on the Acquisition of U.S. Gold Corp.

Press Release – New York, NY – May 31, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced that it has represented Dataram Corporation (NASDAQ: DRAM), a manufacturer of memory products and provider of performance solutions, in its acquisition of U.S. Gold Corp., an exploration stage mining company. The Sichenzia Ross Ference Kesner LLP team was led by Partners Harvey Kesner and Tara Guarneri-Ferrara and associate Nazia Khan.

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar & Co. and Brookline Capital Markets in a $13.25 PIPE for MRI Interventions, Inc.

mri interventions

Press Release – New York, NY – May 26, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC, as lead Placement Agent and Brookline Capital Markets, a division of CIM Securities, LLC, as co-Placement Agent in a $13.25 Million PIPE transaction for MRI Interventions, Inc. (OTCQB: MRIC) a medical device company that is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain.

continue reading >>

Sichenzia Ross Ference Kesner LLP Attorneys Marc Ross and Mendy Piekarski Achieve Complete Dismissal of Shareholder Derivative Lawsuit

Press Release – New York, NY – May 24, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP recently achieved a complete dismissal of a shareholder derivative lawsuit. The shareholder plaintiff filed the derivative lawsuit in Arizona state court, asserting claims against former and current directors and officers of a company that had issued a restatement of its financial statements.

continue reading >>

Sichenzia Ross Ference Kesner Associate Cass Sanford Quoted in Business Insider Article on Topics Surrounding Reg A+

Press Release – New York, NY – May 12, 2017 – Sichenzia Ross Ference Kesner LLP associate Cass Sanford was recently quoted in a Business Insider article, sharing her insight surrounding Regulation A+ investment offerings, and why the JOBS Act mechanism for raising capital should still be considered in its infancy.

continue reading >>

Sichenzia Ross Ference Kesner LLP Advises PolarityTE, Inc. on Acquisition of Intellectual Property Related to Regenerative Medicine

Press Release – New York, NY – May 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced that it has represented PolarityTE, Inc. (NASDAQ: COOL), a company which has developed and distributed software through online platforms and is also engaged in regenerative medicine, in its acquisition of intellectual property related to a novel regenerative medicine and tissue engineering platform developed by Dr. Denver Lough, the Company’s current Chief Executive Officer. The Sichenzia Ross Ference Kesner LLP team was led by Partners Harvey Kesner and Tara Guarneri-Ferrara and associate Nazia Khan. continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. in $5.2 Million Public Offering

onconova logo

Press Release – New York, NY – May 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as sole book-running manager in the underwritten public offering of equity securities of Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). In connection with the offering, Onconova received approximately $5.2 million in gross proceeds from common stock sold at a price to the public of $2.10 per share.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Cooltech Holding Corp. in a Private Placement of $2.9 Million in Common Stock

cool tech logo

Press Release – New York, NY – May 1, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Cooltech Holding Corp. (“Cooltech”), a consumer electronics, mobility and accessories distribution and marketing company, in connection with its sale of $2,859,000 of common stock to accredited investors. Cooltech sold 1,143,600 shares of common stock at a purchase price of $2.50 per share, pursuant to a private placement memorandum and related securities purchase agreement. Laidlaw & Company (UK) Ltd. acted as the placement agent for the private placement.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Marathon Patent Group, Inc. in $2.66 Million Registered Direct Offering

marathon patent group

Press Release – New York, NY – April 24, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Marathon Patent Group, Inc. (Nasdaq: Mara), an IP licensing and commercialization company, in a registered direct public offering of 3,800,000 registered shares of its common stock and 2,280,000 warrants at a price of $0.70 per share for gross proceeds of approximately $2,660,000.
continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for $2.1 Million Private Placement

protea biosciences

Press Release – New York, NY – April 17, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that between November 2016 and March 2017 it represented Laidlaw & Company (UK) Ltd. as the exclusive placement agent in a private placement of equity securities of Protea Biosciences Group, Inc. (OTCQB: PRGB), a molecular information company that has developed a technology which enables the direct analysis, mapping and display of biologically active molecules in living cells and tissue samples.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Tonix Pharmaceuticals Holding Corp. in $8 Million Shelf Take Down

tonix pharmaceuticals

Press Release – New York, NY – April 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Tonix Pharmaceuticals Holding Corp. (“Tonix”), a company that is developing innovative pharmaceutical products to address public health challenges, in connection with its underwritten public offering of 1,800,000 shares of its common stock at an offering price of $4.45 per share of common stock.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Investor in a Private Placement of up to $5,000,000 in Series B Preferred Stock of Digital Power Corporation

Press Release – New York, NY – March 29, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Philou Ventures, LLC (“Philou”) in connection with its entry into a Preferred Stock Purchase Agreement (the “Purchase Agreement”) with Digital Power Corporation, a California corporation (the “Company”), a solution-driven organization that designs, develops, manufactures and sells high-grade customized and flexible power system solutions for applications in the medical, military, telecom and industrial markets.  The Purchase Agreement was executed on March 9, 2017.

continue reading >>

Sichenzia Ross Ference Kesner LLP Partner Gregory Sichenzia Featured in Article Discussing Uptick in Coal and Gas IPOs

Press Release – New York, NY– March 28, 2017 – Sichenzia Ross Ference Kesner LLP founding partner Gregory Sichenzia was recently interviewed by Law360 about the return of coal and gas issuers to the initial public offering landscape after a long absence. Greg attributed the boost partly to a change in administration, as investors expect a friendlier regulatory environment under the Trump administration. The article, titled “Coal Cos. Are Forging A Return To The IPO Pipeline,” is available here.

Sichenzia Ross Ference Kesner LLP Advises Laidlaw & Co. (UK) Ltd. on U.S. Public Offering and NASDAQ Listing of Israeli Cannabinoid Research Company Therapix Biosciences, Ltd. (TRPX)

therapix biosciences logo

Press Release – March 27, 2017 – New York, NY – Sichenzia Ross Ference Kesner LLP (“SRFK”) announced today the successful completion of a U.S. underwritten public offering of American Depositary Shares by Therapix Biosciences Ltd. (“Therapix”) an Israeli public company.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents XTL Biopharmaceuticals Ltd., in a $2.8 Million Private Placement of ADSs.

xtlbio logo

Press Release – New York, NY – March 22, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented XTL Biopharmaceuticals Ltd.  (“XTLB. NASDAQ”), an Israeli biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of lupus and other autoimmune diseases, in a private placement offering with existing investors where XTLB issued 1,400,000 American Depository Shares (ADSs) at a purchase price of $2.00 per ADS.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in $3.85 Million Public Offering of Innovus Pharmaceuticals, Inc.

innovus pharma

Press Release – New York, NY – March 21, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw a unit of H.C. Wainwright as Exclusive Placement Agent in the public offering of common stock and Warrants of Innovus Pharmaceuticals, Inc. (“INNV.OTC).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $3.5 Million Public Offering

pareteum logo

Press Release – New York, NY – March 20, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSEMKT: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in an underwritten public offering of 2,333,334 shares of common stock at a public offering price of $1.50 per share together with the issuance of 1,166,667 five year warrants to purchase common stock with an exercise price of $1.87.

continue reading >>

Sichenzia Ross Ference Kesner LLP Partner Gregory Sichenzia Discusses Shareholder Comments that Impact Stock Price

Press Release – New York, NY– March 13, 2017 – Sichenzia Ross Ference Kesner LLP founding partner Gregory Sichenzia was recently interviewed by Business Insider about comments on Pandora stock by Liberty Media CEO Greg Maffei.  The article, titled “This media mogul has wreaked havoc on Pandora’s stock price for months — and he’s not slowing down,” discusses recent positive and negative comments by Mr. Maffei about Pandora. Greg addressed the legality of public statements that can impact stock price. 

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Cannabinoid Based Therapeutics Company in $12.3 Million Private Placement Led by Tuatara Capital Fund I, Ltd.

Press Release – New York, NY – March 2, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented a cannabinoid based life sciences corporation whose technology is designed to synthetically produce medically beneficial cannabinoids without utilizing the actual cannabis plant for the customized treatment of disease.

continue reading >>

Sichenzia Ross Ference Kesner LLP Founding Partner Gregory Sichenzia Featured in CNBC Story on Investing in Start-ups

Press Release – New York, NY – March 3, 2017 – Founding Partner Gregory Sichenzia was recently featured in a CNBC article authored by Kayleigh Kulp. The article entitled, “New Horizons: How to Invest in a Startup,” reviews the many things investors must know to effectively evaluate and invest in a start up.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Aegis Capital Corp. and Laidlaw & Company (UK) Ltd. in $4.8 Million Public Offering

functionx logo

Press Release – New York, NY – February 28, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Aegis Capital Corp. and Laidlaw & Company (UK) Ltd. as joint book-running managers in the underwritten public offering of common stock of Function(x) Inc. (NASDAQ: FNCX).  Function(x) operates Wetpaint.com and Rant.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management as Warrant Agent in $2.3 Million Warrant Exchange and Exercise for AYTU BioScience, Inc.

aytu bioscience

Press Release – New York, NY – February 28, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC and Fordham Financial Management, Inc. as warrant solicitation agents in a $2.3 warrant exchange and exercise for Aytu Bioscience, Inc. (OTCQB “AYTU”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Medovex Corp. in $4.15 Million Private Placement and Debt Conversion

medovex corporation

Press Release – New York, NY – March 1, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented Medovex Corp. (NASDAQ:MDVX), a medical products manufacturer, in a private placement of units consisting of 3,071,634 shares of common stock and 1,535,817 warrants to purchase common stock at a fixed price of $1.04 per unit resulting in gross proceeds of $3,022,000.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents XTL Biopharmaceuticals Ltd. in $2.5 Million Registered Direct Offering

xtlbio logo

Press Release – New York, NY – February 27, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented XTL Biopharmaceuticals, Ltd. (NASDAQ: XTLB) (TASE: XTL.TA), an Israeli clinical-stage biopharmaceutical company developing treatments for autoimmune diseases, in a registered direct offering of 1,000,000 American Depository Shares (“ADSs”) at a price of $2.50 per share and unregistered warrants to purchase 1,000,000 ADSs at an exercise price of $4.10 per ADS for gross proceeds of $2,500,000. continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. in $7 Million Public Offering

evoke pharma logo

Press Release – New York, NY – February 24, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as sole book-running manager in the underwritten public offering of equity securities of Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases. continue reading >>

Sichenzia Ross Ference Kesner LLP Founding Partner Gregory Sichenzia Discusses Delay of Fiduciary Rule on CNBC

Press Release – New York, NY– February 10, 2017 – Founding partner Gregory Sichenzia discussed the Trump administration’s potential rollback of the new fiduciary rule applicable to broker-dealers that was to go into effect in April 2018.  Greg noted that this new standard is likely to lead to substantial regulatory costs and may not result in better products or targeted advice.

 To view the video, click here.

Sichenzia Ross Ference Kesner LLP Partner Henry Nisser Interviewed by FinOps Report About Improper Handling of ADRs

Press Release – New York, NY – February 1, 2017 – Sichenzia Ross Ference Kesner LLP partner Henry Nisser was interviewed by the FinOps Report in its article titled “Pre-Release ADRs: More SEC Fines on the Way?” The article discusses ITG Inc.’s recent agreement to pay more than $24.4 million to settle charges that it violated federal securities laws when it prompted the issuance of American Depository Receipts (ADRs) without possessing the underlying foreign shares.  continue reading >>

Sichenzia Ross Ference Kesner LLP Appoints Avital Even-Shoshan as Partner

Press Release – New York, NY– January 17, 2017 – The law firm of Sichenzia Ross Ference Kesner LLP today announced the promotion of Avital Even-Shoshan to partner.

“I am proud to congratulate Avital on this well-deserved promotion, which reflects her notable commitment to legal excellence and client service,” said founding partner Gregory Sichenzia. continue reading >>

Sichenzia Ross Ference Kesner LLP Appoints Morgan Weber as Counsel

New York, NY – January 17, 2017 – The law firm of Sichenzia Ross Ference Kesner LLP today announced the promotion of Morgan Weber to counsel.   

Morgan Weber, with over ten years of experience, is versed in complex litigation, in state and federal courts as well as before arbitration tribunals and regulatory agencies. She has substantial experience in litigation motion practice, discovery and trial preparation and appellate work in subjects relating to complex contracts, business litigation, intellectual property matters and real estate matters.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Vycor Medical Inc. in an Internet Portal-based Private Placement

vycor medical inc.

Press Release – New York, NY – January 13, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Vycor Medical Inc. (OTCQB:VYCO) in a private placement with the Company’s existing accredited investor shareholders that was conducted  through an internet portal through which the Company provided potential investors with the offering  documents and accepted subscriptions.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia and David Manno.

continue reading >>

Sichenzia Ross Ference Kesner LLP Founding Partner Marc J. Ross Discusses Employment Issues Surrounding Marijuana Use

Press Release – New York, NY – December 18, 2016 – Sichenzia Ross Ference Kesner LLP Founding Partner Marc J. Ross was recently quoted in The Atlantic, a CityLab article titled “Don’t Bet Your Job on Legal Pot.” The article notes that because marijuana remains illegal under federal law, employers are still able to fire employees for using marijuana, whether medical or recreational, even when such use is permissible under state law.

continue reading >>

Sichenzia Ross Ference Kesner LLP Adds Noted Intellectual Property Lawyer Scott H. Kaliko to Head the Firm’s New IP Group

Press Release — New York, NY — December 19, 2016 — Sichenzia Ross Ference Kesner LLP (“SRFK”), highly respected for their work in the securities and capital markets industries, continued its expansion and diversification for the firm’s practice today and announced the addition of noted intellectual property lawyer Scott H. Kaliko as Counsel to the firm to head the firm’s new intellectual property group. Kaliko joins SRFK from his own firm, Kaliko & Associates, LLC of thirteen years, prior to which he held roles at JP Morgan Chase & Co., and Fish & Neave, LLP (now Ropes & Gray, LLP).

continue reading >>

Sichenzia Ross Ference Kesner Partner Harvey Kesner Quoted on DTC Rule Changes

Press Release – New York, NY – December 15, 2016 – Sichenzia Ross Ference Kesner LLP partner Harvey Kesner was quoted by the FinOps Report in an update to its article titled “Transfer Agents, DTC Still Chilly On Issuer Freeze Policies.” The article discusses the Depository Trust Company’s (DTC) rule changes which specify four circumstances under which the DTC can “chill” or “lock” issuers out of its services. The SEC is responsible for approving any rule changes made by the DTC, the US national depository, and approved the new rules on December 6, 2016.
continue reading >>

Sichenzia Ross Ference Kesner LLP Attorneys Harvey Kesner, Michael Ference, Sameer Rastogi, and Mendy Piekarski Prevail in Removing a Shareholder Derivative Lawsuit to Federal Court

Press Release – New York, NY – December 14, 2016 – Sichenzia Ross Ference Kesner LLP today announced that attorneys Harvey Kesner, Michael Ference, Sameer Rastogi and Mendy Piekarski prevailed in removing a shareholder derivative lawsuit to federal court.

continue reading >>

Founding Partner Marc J. Ross, Esq. Quoted on Impact of Trump AG Pick on Legal Cannabis Industry

Press Release – New York, NY – December 9, 2016 – Sichenzia Ross Ference Kesner LLP founding partner Marc J. Ross, Esq. was recently quoted in a Boston Globe article titled “Trump AG pick could halt legal pot industry,” where he commented on the future of the Marijuana Industry.  The article discusses how Senator Jeff Sessions, Donald Trump’s nominee for attorney general, who many think has a long history of opposition to marijuana, could impact the marijuana industry across the United States.  In particular, Sessions could choose to remove the Cole Memorandum, effectively repealing the protections that exist for marijuana and marijuana-related businesses in the states where marijuana is legal.  
continue reading >>

Founding Partner Marc J. Ross Quoted in Forbes Article on Marijuana Entrepreneurs Who Want Donald Trump to See Them as Job Creators

Press Release – New York, NY – December 6 – Sichenzia Ross Ference Kesner LLP founding partner Marc J. Ross, Esq. was recently quoted in a Forbes article titled “Marijuana Industry Entrepreneurs Want Donald Trump To See Them As Job Creators.” The article discusses that even though Donald Trump’s selection of anti-drug hardliner Alabama Senator Jeff Sessions for his attorney general nominee has entrepreneurs in the legal marijuana industry worried, there is hope that the cannabis sector’s positive impact on job creation and tax revenues will influence Donald Trump to maintain the existing legal protections for marijuana businesses.  

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Oppenheimer & Co. in $3.6 Million PIPE for Ener-Core, Inc.

ener-core

Press Release – New York, NY – December 5, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Oppenheimer & Co., as Sole Placement Agent in private placement of $3.6 Million principal amount of convertible senior secured notes and warrants of Ener-Core, Inc.  (OTCQB. “ENCR”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $14.5 Million Registered Direct Offering.

vuzix view the future logo

Press Release – New York, NY – December 2, 2016 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 2 million registered shares of its common stock at a price of $7.25 per share for gross proceeds to Vuzix of $14,500,000. Chardan Capital Markets LLC acted as the exclusive Placement Agent for the offering. The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Thomas Rose, Marcelle Balcombe and Counsel Jeff Cahlon.

Founding Partner Marc J. Ross Quoted on Inc.com on First Marijuana-Related Listing on the NYSE

Press Release – New York, NY – December 6, 2016 – Sichenzia Ross Ference Kesner LLP founding partner Marc J. Ross, Esq was quoted in an Inc.com article titled “NYSE Lists First Cannabis-Related Company.” The article discusses the IPO and NYSE listing of Innovative Industrial Properties, Inc., which will conduct business as an umbrella partnership real estate investment trust. The company focuses on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Oppenheimer & Co. and Feltl and Company in $13.5 Million PIPE for Midwest Energy Emissions Corp.

midwest energy

Press Release – New York, NY – November 18, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Oppenheimer & Co., as lead Placement Agent and Feltl and Company as Co-Placement Agent in a private placement offering of Common Stock ofMidwest Energy Emissions Corp. ME2C (OTCQB. “MEEC”). continue reading >>

Ten SRFK LLP Attorneys Named Super Lawyers & Rising Stars

Press Release — New York, NY — November 4, 2016  — Sichenzia Ross Ference Kesner LLP is pleased to announce that four partners have once again been named 2016 Super Lawyers. Additionally six other attorneys have been named 2016 Rising Stars.

Super Lawyers, a Thomson Reuters business, is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high degree of peer recognition and professional achievement. Each year, no more than five percent of the lawyers in New York  are selected by the research team at Super Lawyers to receive this honor.

The attorneys who have been selected for the 2016 honors are:  continue reading >>

Sichenzia Ross Ference Kesner LLP Selected to ‘Best Law Firms’ by US News and World Report

Press Release — New York, NY — November 3, 2016 – Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has been selected in the 7th Edition of Best Law Firms by US News & World Report for 2017 under the category of Corporate Law.  In addition, Founding Partner, Gregory Sichenzia has also been listed in Best Lawyers under the category of Corporate Law since 2016.

Sichenzia Ross Ference Kesner LLP Congratulates TapImmune Inc. on NASDAQ Uplisting

New York, NY – November 3, 2016 – Sichenzia Ross Ference Kesner LLP announced today that the Firm has represented TapImmune Inc. (NASDAQ: TPIV), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross  Ference Kesner LLP team was led by founding Partner Gregory Sichenzia and Associate Jay Yamamoto. The uplisting is effective for trading on November 8, 2016 and TapImmune’s common stock will trade under its existing stock symbol “TPIV.”

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, Feltl and Company and Fordham Financial Management in $8.6 Million Public Offering of Aytu Bioscience, Inc.

aytu bioscience

Press Release – New York, NY – November 2, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co. and Feltl and Company as Joint Book -Running Managers and Fordham Financial Management, Inc. as Lead Manager in a firm commitment underwritten public offering of equity securities of Aytu BioScience, Inc.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Tonix Pharmaceuticals in $5.2 Million Public Offering

tonix pharmaceuticals

Press Release – New York, NY – November 1, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Tonix Pharmaceuticals Holding Corp. (NASDAQ “TNXP”), a developer of next-generation medicines for common disorders of the central nervous system, continue reading >>

Sichenzia Ross Ference Kesner LLP Represents ToughBuilt Industries, Inc. in $6.1 Million Private Offering

toughbuilt logo

Press Release – New York, NY – October 18, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented ToughBuilt Industries, Inc. (“ToughBuilt”) in a private placement of equity as well as debt securities.  ToughBuilt is a private company that markets and distributes various home improvement and construction product lines for both do-it-yourself and professional markets under the TOUGHBUILT® brand name within the global multi-billion dollar per year tool market industry.

continue reading >>

Sichenzia Ross Ference Kesner LLP Announces Change of Name

New York, New York October 17, 2016 — Sichenzia Ross Ference Kesner LLP, a leading securities and corporate law firm, is pleased to announce that Harvey Kesner has joined Gregory Sichenzia, Marc Ross and Michael Ference in renaming the firm “SRFK LLP.”  The newly renamed law firm represents the continuation of the firm’s 18 year commitment to excellence through serving the needs of public and private companies, their financiers and the broker-dealer and financial services community. The firm, previously named Sichenzia Ross Friedman Ference LLP and founded by Gregory Sichenzia, Marc Ross and Michael Ference 18 years ago, first welcomed Harvey Kesner as a partner in 2009.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents ABT Holdings, Inc. in $5 Million Private Offering of Senior Secured Convertible Debentures

abt logo

October 17, 2016 — New York, NY — Sichenzia Ross Ference Kesner LLP has represented ABT Holdings, Inc. (OTC.PK: ABOT), a diversified holding company engaged in investing, acquiring, developing, and growing various businesses, in a private offering of $5 Million of Senior Secured Convertible Debentures. continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for a $3 Million Private Placement

fte networks logo

Press Release – New York, NY – October 17, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as the exclusive placement agent in a private placement of equity securities of FTE Networks, Inc. (OTCQX: FTNW), continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Network 1 Securities in $7.7 Million IPO and NASDAQ listing of ShineCo, Inc.

shineco inc

Press Release – New York, NY – September 30, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it represented Network 1 Financial Securities, Inc. as underwriter in a $7.7 million best efforts Initial Public Offering of 1,713,190 shares of common stock of ShineCo, Inc. (Nasdaq TYHT) at a public offering price of $4.50 per share. Monarch Bay Securities participated as a selected dealer. Shineco is a producer and distributor of Chinese herbal medicines, organic agricultural produce and other health based plant products in China. The Sichenzia Ross Friedman Ference LLP team was led by Partners Marc Ross and Henry Nisser.

continue reading >>

Sichenzia Ross Friedman Ference LLP Represents BioPharmX Corporation in $930,000 Registered Direct Offering

biopharmx

Press Release – New York, NY – September 29, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it has represented BioPharmX Corporation (NYSE. MKT “ BPMX) in a Registered Direct public offering of 1,550,000 registered shares of its common stock at a price of $.60 per share and 1,240,000 unregistered warrants to purchase common stock at an exercise price of $.75 per share for gross proceeds to BPMX of $930,000. Rodman & Renshaw a Unit of H.C. Wainwright & Co., LLC acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe and Counsel Jeff Cahlon.

continue reading >>

1 2 3 4